Citadel Advisors
ELX

Citadel Advisors’s EMULEX CORP ELX Stock Holding History

Citadel Advisors’s Portfolio ELX Stock Details ELX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-13,600
Closed -$108K – 9463
2015
Q1 		$108K Sell
13,600
-6,400
-32% -$44.9K ﹤0.01% 6783
2014
Q4 		$113K Buy
20,000
+12,700
+174% +$68.4K ﹤0.01% 6547
2014
Q3 		$36K Sell
7,300
-3,800
-34% -$20.6K ﹤0.01% 7115
2014
Q2 		$63K Buy
11,100
+10,100
+1,010% +$60.1K ﹤0.01% 6592
2014
Q1 		$7K Sell
1,000
-12,500
-93% -$91.9K ﹤0.01% 7614
2013
Q4 		$97K Sell
13,500
-9,300
-41% -$69K ﹤0.01% 5642
2013
Q3 		$177K Buy
22,800
+6,500
+40% +$50.5K ﹤0.01% 4878
2013
Q2 		$106K Buy
+16,300
New +$103K ﹤0.01% 5185

Citadel Advisors's ELX Position: Q2 2015 in Review

Citadel Advisors sold out of EMULEX CORP (ELX) in Q2 2015, closing a stake of 20,188 shares — an estimated $161K sold.

Citadel Advisors first reported a position in ELX in Q2 2013 and held it in 8 quarters. The position peaked at $2.44M in Q1 2014. 0 funds tracked by Wall St. Rank hold ELX as of Q2 2015.

  • Citadel Advisors reported no remaining EMULEX CORP position as of Q2 2015 after selling out during the quarter.
  • Citadel Advisors sold 20,188 EMULEX CORP shares in Q2 2015, an estimated $161K.
  • Citadel Advisors first reported a position in EMULEX CORP in Q2 2013 and held it in 8 quarters.
  • Citadel Advisors's EMULEX CORP position peaked at $2.44M in Q1 2014.
  • 0 funds tracked by Wall St. Rank held EMULEX CORP as of Q2 2015.

Based on Citadel Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.